MedPath

Rowpar Pharmaceuticals, Inc.

Rowpar Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
1991-01-01
Employees
11
Market Cap
-
Website
http://rowpar.com

Clinical Trials

4

Active:0
Completed:4

Trial Phases

3 Phases

Phase 2:1
Phase 4:1
Not Applicable:2

Drug Approvals

6

FDA:4
CANADA:1

Drug Approvals

CloSYS Silver Healthy Gums

Approval Date
May 16, 2025
FDA

CloSYS

Approval Date
May 16, 2025
FDA

CloSYS Silver Sensitive Mouth Rinse

Approval Date
May 16, 2025
FDA

CloSYS

Approval Date
May 16, 2025
FDA

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (50.0%)
Phase 2
1 (25.0%)
Phase 4
1 (25.0%)

Efficacy of ClōSYS® Sensitive Fluoride Toothpaste and ClōSYS® Sensitive Rinse Regimen on MGI, PI and BOP

Phase 2
Completed
Conditions
Gingivitis
Periodontitis
Interventions
Drug: ClōSYS® Sensitive Fluoride Toothpaste
Other: ClōSYS® Sensitive Rinse
First Posted Date
2022-02-28
Last Posted Date
2025-08-15
Lead Sponsor
Rowpar Pharmaceuticals, Inc.
Target Recruit Count
60
Registration Number
NCT05258721
Locations
🇺🇸

Arizona School of Dentistry & Oral Health, Mesa, Arizona, United States

The Efficacy of Stabilized Chlorine Dioxide Rinse as a Chemical Adjuvant for Treatment of Per-implant Mucositis

Phase 4
Completed
Conditions
Peri-implant Mucositis
Interventions
Other: Placebo
Drug: Stabilized chlorine dioxide oral rinse
First Posted Date
2021-04-08
Last Posted Date
2022-04-14
Lead Sponsor
Rowpar Pharmaceuticals, Inc.
Target Recruit Count
57
Registration Number
NCT04838054
Locations
🇺🇸

Stony Brook University, Stony Brook, New York, United States

Controlling Oral Malodor by ClōSYS® Oral Rinse

Not Applicable
Completed
Conditions
Oral Malodor
Interventions
Drug: ClōSYS® Flavored Rinse
Drug: ClōSYS® Unflavored Rinse
Other: Placebo
First Posted Date
2017-05-19
Last Posted Date
2021-01-07
Lead Sponsor
Rowpar Pharmaceuticals, Inc.
Target Recruit Count
100
Registration Number
NCT03160560

Controlling Oral Malodor by ClōSYS Oral Rinse

Not Applicable
Completed
Conditions
Oral Malodor
Interventions
Drug: ClōSYS® Unflavored Rinse
Other: Placebo-Flavored Oral Rinse
Other: Placebo-Unflavored Oral Rinse
Drug: ClōSYS® Flavored Rinse
First Posted Date
2017-05-19
Last Posted Date
2020-12-22
Lead Sponsor
Rowpar Pharmaceuticals, Inc.
Target Recruit Count
99
Registration Number
NCT03160573

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.